The UK nanomedicines market is projected to grow at a modest CAGR of 10.7% during the forecast period (2021-2027). The major aspect that drives the growth of the market includes the well-established healthcare sector in the country that focuses on the development of novel and advanced techniques for the treatment of various diseases. Besides, the country is also home to numerous research academies and major market players. As of July 2019, the UK takes second place across the globe, in terms of its number of national nanotechnology standards, with overall 118 standards. Some of the key companies that are focused on R&D in the country are Manchester-based 2-DTech, BREC Solutions, Efficiency Technologies, and Graphitene among many others which are engaged in nanotechnology.
To Request a Sample of our Report on UK Nanomedicines Market: https://www.omrglobal.com/request-sample/uk-nanomedicines-market
The UK nanomedicines market is segmented on the basis of indication type and application. Based on the indication type, the market is segmented as cardiovascular diseases, neurological diseases, infectious diseases, oncological diseases, orthopedic diseases, and others. The other segment includes urological disease and ophthalmic diseases. The cardiovascular diseases segment is likely to hold a substantial share in the market over the forecast period. Based on the applications, the market is segmented as drug delivery, active implants, vaccines, diagnostic imaging, biomaterials, regenerative medicines, and other applications. The other segment includes tissue regeneration. The drug delivery segment is likely to hold a substantial share in the market over the forecast period.
(Get 15% Discount on Buying this Report)
A full Report of UK Nanomedicines Market is Available at: https://www.omrglobal.com/industry-reports/uk-nanomedicines-market
UK Nanomedicine Market Segmentation
By Indication Type
· Cardiovascular Diseases
· Neurological Diseases
· nfectious Diseases
· Oncological Diseases
· Orthopedic Diseases
· Other Diseases (Urological Disease, Ophthalmic Diseases)
By Application
· Drug Delivery
· Active Implants
· Vaccines
· Diagnostic Imaging
· Biomaterials
· Regenerative Medicines
· Other Applications (Tissue Regeneration)
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
